Ultragenyx Pharmaceutical | RARE - Ebit




Ultragenyx Pharmaceutical reported $-122278000 in EBIT for its fiscal quarter ending in December of 2024.

Ebit Change Date
Acadia Pharmaceuticals USD 31.64M 1.21M Sep/2024
Agios Pharmaceuticals USD -125037000 22.23M Dec/2024
Alnylam Pharmaceuticals USD -105159000 28.25M Dec/2024
BioMarin Pharmaceutical USD 161.41M 47.51M Dec/2024
Insmed USD -245214000 31.78M Dec/2024
Ionis Pharmaceuticals USD -110000000 38M Dec/2024
Kyowa Hakko Kirin JPY 29.15B 10.86B Jun/2024
MacroGenics USD 54.52M 112.7M Sep/2024
Moderna USD -1246000000 1.18B Dec/2024
Neurocrine Biosciences USD 142M 41.8M Dec/2024
PTC Therapeutics USD -54510000 12.27M Sep/2024
Regeneron Pharmaceuticals USD 1.57B 67.9M Dec/2024
Sarepta Therapeutics USD 22.2M 3.79M Sep/2024
Ultragenyx Pharmaceutical USD -122278000 9.71M Dec/2024
Vertex Pharmaceuticals USD 1.2B 108.8M Dec/2024